Advertisement
03/03/2021

NuSachi taps Storey to lead global business development

David Salazar
Managing Editor
David Salazar profile picture
Image
a man wearing a suit and tie
Matt Storey, photo by Malek Asfeer

Nashville-based NuSachi is bringing on a cannabis industry and CPG veteran to head up its sales and business development. Matt Storey has been named senior vice president of global business development for NuSachi, which offers expertise and services from hemp genetics to custom formulations and white and private labeling. 

In his new role, Storey is charged with creating formulation and co-production partnerships in the hemp, cannabis, wellness, personal care and food and beverage sectors. 

“Matt Storey guided growth for a worldwide CBD leader and is accomplished in building brands that utilize botanicals to promote well-being,” said Tonya Lewis, chief marketing officer and co-founder of NuSachi. “Whether white label, private label, or a completely innovative new idea, we look forward to Matt’s work in helping NuSachi clients stand out with high-end custom product lines.”

Among Storey’s experience in the cannabis industry is his work with Charlotte’s Web, which he joined in 2015 to help scale the company into one of the hemp industry’s leading companies. He also has consulted with brands worldwide to lead the launch of various CBD and cannabis brands. Since 2001, he has held various roles within the CPG, nutraceuticals, CBD and hemp industries. A former member of the Army Special Forces, Storey moved into the natural health space after finding a passion for alternatives in healing. 

“NuSachi has done the hardest things first and built a totally transparent, medical-grade supply chain for hemp and related products,” Storey said. “Proud to be part of team NuSachi, I’m eager to show the breadth of what we do and how we do it — especially our precision custom product formulation work.”

Storey’s appointment follows the company’s promotion of J. Mitchell to serve as NuSachi president and Clint Southern’s appointment to the role of CFO.